Patented Medicine Prices Review Board
We are in the process of moving our services and information to Canada.ca.
Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.
Canada’s drug price watchdog ready to apply new powers to protect Canadians from surging high cost drugs
Oncology Medicines in Canada: Trends and International Comparisons, 2010–2019
Oncology medicines are an increasingly important driver of Canadian pharmaceutical sales.
What we are doing
The PMPRB is responsible for ensuring the prices that patentees charge for prescription and non-prescription patented medicines sold in Canada to wholesalers, hospitals, pharmacies or others, for human and veterinary use, are not excessive.
Every report and publication published by the NPDUIS group.
Effective and meaningful stakeholder involvement is essential to enable the PMPRB to fulfil its mandate, deliver programs, launch new initiatives, and build public trust.
Report a problem or mistake on this page
- Date modified: